April 23, 2021 – At the four-and-a-half year follow-up, 71 to 100 percent of participants credited improvements in levels of anxiety and depression to the single-dose psilocybin and therapy combination of the study. The participants further “rated it among the most personally meaningful and spiritually significant experiences of their lives.”
Though further research needs to be done, it’s thought that because psilocybin can affect mood and perception to “regulate arousal and panic responses,” the drug interacts with the networks of the brain to shape it into being more amenable to entertaining new thought patterns.
Researchers believe that psilocybin can be beneficial to patients by strengthening the effects of psychotherapy and aiding in a larger-spanning reduction in symptoms.
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…